Real-time enrollment status for this urinary bladder neoplasms clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 3:45 PM UTC
| NCT Number | NCT05614739 |
| Recruiting Status | Recruiting |
| Condition | Urinary Bladder Neoplasms |
| Phase | PHASE1 |
| Target Enrollment | 677 participants |
| Active Locations | 41 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | August 20, 2026 (1 week ago) |
As of August 27, 2026: Clinical trial NCT05614739 is currently recruiting participants. This phase1 study for urinary bladder neoplasms is actively seeking new participants at 41 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05614739 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 41 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05614739 was last updated 1 week ago (August 20, 2026). HelloStudys verifies this status automatically.